Trial Profile
Four-Period, Single-Dose, Sequential Study in Healthy Adults, to Assess Pharmacokinetics of ALZ-801 and Tramiprosate From ALZ-801 Prototype Tablets and Effect of Food on Bioavailability of ALZ-801 and Tramiprosate for Selected Prototype Tablet
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2020
Price :
$35
*
At a glance
- Drugs Valiltramiprosate (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Alzheon
- 23 Oct 2017 Results published in the Clinical Pharmacokinetics
- 17 Jul 2017 According to an Alzheon meddia release, data from this trial will be presented at the Alzheimers Association International Conference 2017.
- 30 Mar 2017 Results from this and another phase Ib trial (CT profile 700266591) Presented at the 13th International Conference on Alzheimer's and Parkinson's Diseases, according to an Alzheon Inc. media release.